Status:
RECRUITING
Hemodynamic Monitoring and Fluid Responsiveness in Venovenous Extracorporeal Membrane Oxygenation (VV ECMO) - "HemodynamECMOnitoring-VV Study"
Lead Sponsor:
Medical University of Vienna
Conditions:
ECMO Treatment
ARDS
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
In extracorporeal membrane oxygenation (ECMO), blood is drawn out of the body via tubes, oxygenated in an artificial lung; and then pumped back into the blood vessels. This allows the supply of oxygen...
Detailed Description
Hemodynamic monitoring and tests for fluid responsiveness are cornerstones of intensive care medicine. Generally, hemodynamic measurements can be obtained, for instance, with the following methods: p...
Eligibility Criteria
Inclusion
- Patient receiving VV-ECMO support
- Age 18 - 75 years
Exclusion
- Pregnancy
- Conditions not allowing for passive leg raising maneuvers, e.g. "open abdomen", known or suspected elevation of intracranial pressure, recent leg or spinal trauma or orthopedic conditions not permitting leg raising
- Known ischemic or hemorrhagic stroke within 3 months prior to study enrollment.
- Suspicion of raised intracranial pressure is defined as pupil divergence (if not yet further clarified radiographically/neurologically/ophthalmologically) or signs detected in routine computed tomography scans (compressed or elapsed basal cisterns or midline shift \> 5 mm.
Key Trial Info
Start Date :
May 3 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2027
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06593717
Start Date
May 3 2024
End Date
January 1 2027
Last Update
September 29 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical University of Vienna
Vienna, Austria, 1090